This Article Full Text (PDF) Other Versions of this Article: JVI.02360-06v1 81/11/5637    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burrer, R. Articles by Buchmeier, M. J. Search for Related Content PubMed PubMed Citation Articles by Burrer, R. Articles by Buchmeier, M. J.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.02360-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models

The Scripps Research Institute, Department of Molecular and Integrative Neurosciences, and Department of Cell Biology, 10550 North Torrey Pines Rd., La Jolla, California 92037; AVI Biopharma Inc., 4575 SW Research Way, Corvallis, Oregon 97333

^* To whom correspondence should be addressed. Email: buchm{at}scripps.edu.

	Abstract

The recent emergence of novel pathogenic human and animal coronaviruses has highlighted the need for antiviral therapies that are effective against a spectrum of these viruses. We have used several strains of murine hepatitis virus (MHV) in cell culture and in vivo in mouse models to investigate the antiviral characteristics of peptide-conjugated antisense phosphorodiamidate morpholino oligomers (P-PMO). Ten P-PMO directed against various target sites in the viral genome were tested in cell culture and one of these (5TERM), complementary to the 5'-terminus of the genomic RNA, was effective against six strains of MHV. Further studies were carried out with various arginine-rich peptides conjugated to the 5TERM PMO sequence, in order to evaluate efficacy and toxicity, and thereby select candidates for in vivo testing. In uninfected mice, prolonged P-PMO treatment did not result in weight loss or detectable histopathologic changes. 5TERM P-PMO treatment reduced viral titers in target organs, and protected against virus-induced tissue damage. Prophylactic 5TERM P-PMO treatment decreased the amount of weight loss associated with infection under most experimental conditions. Treatment also prolonged survival in two lethal challenge models. In some cases of high-dose viral inoculation followed by delayed treatment, 5TERM P-PMO was not protective, and increased morbidity in the treated group, suggesting that P-PMO may cause toxic effects in the diseased mouse that were not apparent in the uninfected animal. However, the strong antiviral effect observed suggests that with further development, P-PMO may provide an effective therapeutic approach against a broad range of coronavirus infections.

This article has been cited by other articles:

• Abes, R., Moulton, H. M., Clair, P., Yang, S.-T., Abes, S., Melikov, K., Prevot, P., Youngblood, D. S., Iversen, P. L., Chernomordik, L. V., Lebleu, B. (2008). Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies. Nucleic Acids Res 0: gkn541v1-gkn541 [Abstract] [Full Text]  
• Stein, D. A., Huang, C. Y.-H., Silengo, S., Amantana, A., Crumley, S., Blouch, R. E., Iversen, P. L., Kinney, R. M. (2008). Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus. J Antimicrob Chemother 62: 555-565 [Abstract] [Full Text]  
• Stone, J. K., Rijnbrand, R., Stein, D. A., Ma, Y., Yang, Y., Iversen, P. L., Andino, R. (2008). A Morpholino Oligomer Targeting Highly Conserved Internal Ribosome Entry Site Sequence Is Able To Inhibit Multiple Species of Picornavirus. Antimicrob. Agents Chemother. 52: 1970-1981 [Abstract] [Full Text]  
• Gabriel, G., Nordmann, A., Stein, D. A., Iversen, P. L., Klenk, H.-D. (2008). Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus. J. Gen. Virol. 89: 939-948 [Abstract] [Full Text]  
• Zhang, Y.-J., Bonaparte, R. S., Patel, D., Stein, D. A., Iversen, P. L. (2008). Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus. Molecular Cancer Therapeutics 7: 712-720 [Abstract] [Full Text]  
• Vagnozzi, A., Stein, D. A., Iversen, P. L., Rieder, E. (2007). Inhibition of Foot-and-Mouth Disease Virus Infections in Cell Cultures with Antisense Morpholino Oligomers. J. Virol. 81: 11669-11680 [Abstract] [Full Text]  
• Wu, R. P., Youngblood, D. S., Hassinger, J. N., Lovejoy, C. E., Nelson, M. H., Iversen, P. L., Moulton, H. M. (2007). Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity. Nucleic Acids Res 0: gkm478v1-10 [Abstract] [Full Text]